PeptideStack
5.2kquestions
20kanswers
220users

Is ursodeoxycholic acid prophylaxis supported by anything in this population?

Asked 10 May 2024Modified 23 months agoViewed 44k times
This question was closed as needing detail or clarity.Closed 11 Jun 2024. Answers already posted are preserved; new answers are not accepted. Questions here need enough detail that they can be answered as written.
26

I am asking about the pattern rather than about my own management, which is elsewhere.

I am asking for verification rather than opinion, ideally with something I can read myself.

It is possible the evidence exists and I am searching for the wrong term.

Is this actually true, and what is the evidence?

gallbladder
gallbladder

Cholelithiasis and cholecystitis risk during rapid weight loss and on treatment: how much is attributable to the rate of loss versus to the drug,…

8 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
shareeditfollowflag
BB
askedbac_or_bust33k13710 May 2024

5 Answers

Accepted answer first, then by votes
94

Accepted answer

The short version: rapid loss raises biliary cholesterol saturation and reduces gallbladder emptying, and both push towards stone formation.

Two mechanisms operate together during rapid loss: cholesterol mobilised from adipose tissue is excreted into bile, raising its cholesterol saturation index; and reduced fat intake reduces cholecystokinin release, so the gallbladder contracts less often.

Local reaction versus infection

FeatureLocal reactionSterile abscessCellulitis
OnsetHours to 2 daysDays1–4 days, progressive
WarmthAbsent or minimalMildMarked
ExpansionStatic or shrinkingSlowExpanding
TextureFirm, flat or raisedFluctuantDiffuse, indurated
Systemic featuresNoneNoneFever, malaise possible
ActionObserve, rotate siteClinical reviewSame-day clinical review

Ursodeoxycholic acid has evidence for reducing stone formation during rapid weight loss and is a prescribing decision rather than a supplement choice.

Gallstone formation during rapid weight loss is documented extensively in the very-low-energy diet and bariatric surgery literature, well before any pharmacological interest.

The caveat is that severe abdominal pain with fever or jaundice is an emergency and not a topic for discussion.

Recognise biliary colic: right upper quadrant, after fatty food, thirty minutes to hours.

shareimprove this answerflag
DV
answered · acceptedDr_Bram_Verhoeven84k24830 Jul 2024
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
38

The relevant detail is that this is one of the few adverse outcomes in this class with a clean mechanistic explanation and a clear modifiable factor.

Fever, jaundice or persistent pain beyond a few hours suggests complication rather than simple colic and is urgent.

The trial programmes in this class report cholelithiasis at low single-figure percentages, higher than placebo, consistent with the weight-loss mechanism rather than a novel one.

Ursodeoxycholic acid prophylaxis during rapid weight loss has randomised evidence for reducing stone formation.

Prophylaxis is a prescribing decision that depends on individual risk, not a general recommendation.

This is a weight-loss risk with a known mechanism, not a mysterious drug effect.

shareimprove this answerflag
DZ
answeredDr_Marek_Zielinski27k2719 Jul 2024
I have seen this misattributed to the compound twice when it was the deficit. – tyndall_haze 2 months ago
2Confirming that slowing the titration fixed this rather than any of the other things I tried. – tare_weight 4 months ago
add a comment
25

Concretely, very low fat intake is a contributor rather than a protection, which surprises people.

Loss rates above about 1.5 kilograms a week are where the risk climbs most steeply in the older literature, which is a practical argument against the fastest possible trajectory.

Stated carefully, the historical figure from very-low-energy diet studies is that gallstones form in a substantial minority — often quoted between ten and twenty-five per cent — during rapid loss, with a much smaller fraction becoming symptomatic.

The dual mechanism — raised biliary cholesterol saturation plus reduced gallbladder emptying — is established from bile composition and motility studies.

Research-use compounds are not approved for human use.

Rate of loss is the modifiable factor. Slower is genuinely safer here.

shareimprove this answerflag
DV
answeredDr_Bram_Verhoeven84k24811 Aug 2024
21

The part that matters: biliary colic presents characteristically and is worth being able to recognise.

Including some dietary fat at meals maintains gallbladder contraction. A near-zero-fat diet during rapid loss is the combination that maximises risk, which inverts the intuitive advice.

Trial programmes in this class report cholelithiasis as an adverse event at rates above placebo and consistent with the magnitude of weight loss achieved.

Fever or jaundice with pain is urgent. Do not wait.

edited 23 Jun 2024 by label_claim — removed a claim I could not source

shareimprove this answerflag
LC
answeredlabel_claim30k3816 Jun 2024
-3

The relevant physiology is that mobilised cholesterol is excreted in bile while gallbladder contractility falls with reduced fat intake — a supersaturated bile that is not being emptied.

Biliary colic presents as severe right-upper-quadrant or epigastric pain, often after a fatty meal, lasting from thirty minutes to several hours, sometimes radiating to the right shoulder blade.

The pooled gastrointestinal adverse-event rates across the STEP programme and the SURMOUNT programme are reported in the primary publications and in the FDA and EMA assessment reports, and the assessment reports are more useful because they give the placebo-arm rates alongside the active-arm rates in the same table.

Keep some fat in meals. A zero-fat diet stops the gallbladder emptying.

shareimprove this answerflag
DS
answereddmitri_savchuk27k3822 Aug 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.